Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Japanese Journal of Clinical Oncology|March 12, 2003
Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigationShozo Ohsumi, Goi Sakamoto, Shigemitsu Takashima, et al.Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.Breast Cancer (Tokyo, Japan)|June 28, 2018
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancerDaisuke Takabatake, Yukiko Kajiwara, Shoichiro Ohtani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patientsKazuma Kiyotani, Taisei Mushiroda, Chiyo K Imamura, et al.Breast Cancer (Tokyo, Japan)|April 29, 2005
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumorsYoshifumi Komoike, Futoshi Akiyama, Yuichi Iino, et al.Breast Cancer Research and Treatment|April 15, 2010
Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 studyTomohiko Aihara, Yuichi Takatsuka, Shozo Ohsumi, et al.Cancer|December 8, 2005
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastasesYoshifumi Komoike, Futoshi Akiyama, Yuichi Iino, et al.Breast Cancer (Tokyo, Japan)|July 9, 2024
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, et al.Breast Cancer (Tokyo, Japan)|February 14, 2013
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi, Norikazu Masuda, Hiroji Iwata, et al.Cancer Medicine|November 8, 2022
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriersTomoharu Mori, Yusuke Okamoto, Anfeng Mu, et al.Pageof 13